Senior Manager, Talent Acquisition (contract)
|
Summit Therapeutics, Inc.
San Mateo 94029
Senior Manager, Talent Acquisition (contract) About Summit Ivonescimab, known as SMT112, is a novel, potential first-in-class investigational bispecific antibody combining immunotherapy via PD-1 blockade with anti-angiogenesis effects by blocking VEGF. It exhibits unique cooperative binding with higher affinity when both targets are present. Summit has initiated clinical development of... |
View salary & More Info |
|
a day ago
|
|